Myriad Genetics Names George Daneker Jr., MD, as President
SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
Stay updated with breaking news from Oncology Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
30.01.2024 - SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of ...
SALT LAKE CITY, Jan. 30, 2024 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief...
/PRNewswire/ -- Tampa General Hospital is announcing the appointments of Dr. Warren Jackson "Jack" Pledger, a distinguished cancer researcher, as associate...
Keynote by Admiral Rachel Levine, M.D., Assistant Secretary for Health, U.S. Department of Health and Human Services...